抑制JAK-STAT信号抑制中大血管炎的致病性免疫反应
在PubMed上查看摘要
概括
此摘要是机器生成的。托法西替尼是一种Janus激酶 (JAK) 抑制剂,通过向T细胞并减少血管损伤,有效抑制巨细胞动脉炎的慢性炎症. 这种治疗减少了组织内存的T细胞,并抑制了驱动血管炎的关键途径.
科学领域
- 免疫学
- 心血管医学
- 关节病学
背景情况
- 巨细胞动脉炎 (GCA) 是一种慢性自身免疫性血管炎,影响大动脉,导致动脉瘤和闭塞等并发症.
- 在GCA中持续的炎症涉及效应T细胞和组织内存T细胞,尽管接受皮质类固醇治疗,但会导致慢性血管炎.
- 炎症导致微血管新生和内脏增生, 损害动脉完整性.
研究的目的
- 调查病变T细胞,包括组织内存T细胞,是否在GCA中保持持续的炎症.
- 确定这些T细胞对针对JAK3和JAK1的Janus激酶 (JAK) 抑制剂的敏感性.
主要方法
- 从GCA患者的人类动脉移植到免疫缺陷小鼠中,并与患者的免疫细胞重组.
- 患有动脉炎症的小鼠接受了托法西替尼或载体对照剂的治疗.
- 使用RT-PCR,免疫组织化学和流细胞测量分析了血管炎症,基因/蛋白质表达和免疫细胞群.
主要成果
- 托法西替尼在动脉壁内显著抑制了先天性和适应性免疫力.
- 在对托法西替尼治疗后,损伤性T细胞的增殖和效应分子 (IFN-γ,IL-17,IL-21) 的产生减少.
- 托法西替尼抑制了随机血管生成,减少了内膜增生,减少了CD4+CD103+组织内存T细胞.
结论
- 通过JAK3和JAK1传递细胞因子的信号对于GCA影响的大动脉的慢性炎症至关重要.
- JAK抑制剂托法西替尼有效抑制组织内存T细胞和GCA中的关键血管生成通路.
- 托法西替尼在治疗慢性动脉炎症方面具有潜力.
相关概念视频
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...

